Modalis Therapeutics announces joint research agreement with JCR Pharmaceuticals
Modalis Therapeutics has entered into a collaborative research agreement with JCR Pharmaceuticals, focusing on the joint evaluation of gene therapy drug delivery technology targeting the central nervous system